Henrich Jill
EVP, Chief Regulatory Officer | EVP, Global Head Ra &Quality
1 company
Insider Signal Score
62
GoodTrades Analyzed
7
12M Win Rate
71.4%
Avg 3M Return
+3.3%
Avg 12M Return
+18.4%
Henrich Jill serves as an EVP, Chief Regulatory Officer at ATRA. Across recent SEC filings that breaks down to 0 buys and 9 sells. Those positions are worth an estimated $158K at current prices.
Historically, Henrich Jill's trades have earned a middling insider score of 62/100 across 7 rated trades. Over a 12-month horizon, 71.4% of those trades were profitable, with an average 12-month return of +18.4%.
The biggest single holding is ATRA (~$158K) as EVP, Chief Regulatory Officer. The recent filings there lean toward selling, a net 39,264 shares.
Holdings by Company
ATRAMar 3, 2025
Current Shares18.7K
Value$157.8K
Net Activity-39,264
Bought: 0Sold: 39.3K
Transaction History
Showing 7 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | ATRA Atara Biotherapeutics, Inc. | EVP, Chief Regulatory Officer | Sell | 1,059 | $7.00 | $7,409.82 | -5.4% | +14.3% | -22.6% | |
| Nov 18, 2024 | ATRA Atara Biotherapeutics, Inc. | EVP, Chief Regulatory Officer | Sell | 1,000 | $11.20 | $11,198.00 | -4.9% | -28.7% | +18.8% | |
| Aug 16, 2024 | ATRA Atara Biotherapeutics, Inc. | EVP, Global Head Ra &Quality | Sell | 963 | $6.63 | $6,383.99 | -2.3% | +82.2% | +75.3% | |
| May 16, 2024 | ATRA Atara Biotherapeutics, Inc. | EVP, Global Head Ra &Quality | Sell | 25,750 | $0.62 | $15,887.75 | -4.6% | -48.8% | -54.7% | |
| Mar 4, 2024 | ATRA Atara Biotherapeutics, Inc. | EVP, Global Head Ra &Quality | Sell | 3,879 | $0.72 | $2,792.88 | -0.7% | -23.0% | -62.0% | |
| Nov 16, 2023 | ATRA Atara Biotherapeutics, Inc. | EVP, Global Head Ra &Quality | Sell | 3,267 | $0.39 | $1,270.86 | -3.0% | +60.3% | -0.1% | |
| Aug 16, 2023 | ATRA Atara Biotherapeutics, Inc. | EVP, Global Head Ra &Quality | Sell | 3,346 | $1.65 | $5,531.50 | -1.5% | -79.4% | -83.8% |